Feb. 17, 2020 12:00 UTC NESS ZIONA, Israel--( BUSINESS WIRE )-- BiomX , a microbiome company developing both natural and engineered phage therapies, today announced that the company will present pre-clinical data from its colorectal cancer program at the plenary session of the American Association for Cancer Research (AACR) Microbiome, Viruses, and Cancer Conference taking place from February 21-24, 2020, in Orlando, Florida. BiomX’s colorectal cancer program utilizes phage to targ
February 17, 2020
· 3 min read